NM_001256545.2:c.1514G>A
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001256545.2(MEGF10):c.1514G>A(p.Gly505Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001256545.2 missense
Scores
Clinical Significance
Conservation
Publications
- MEGF10-related myopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001256545.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MEGF10 | NM_001256545.2 | MANE Select | c.1514G>A | p.Gly505Glu | missense | Exon 12 of 25 | NP_001243474.1 | ||
| MEGF10 | NM_032446.3 | c.1514G>A | p.Gly505Glu | missense | Exon 13 of 26 | NP_115822.1 | |||
| MEGF10 | NM_001308119.2 | c.1514G>A | p.Gly505Glu | missense | Exon 13 of 15 | NP_001295048.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MEGF10 | ENST00000503335.7 | TSL:1 MANE Select | c.1514G>A | p.Gly505Glu | missense | Exon 12 of 25 | ENSP00000423354.2 | ||
| MEGF10 | ENST00000274473.6 | TSL:1 | c.1514G>A | p.Gly505Glu | missense | Exon 13 of 26 | ENSP00000274473.6 | ||
| MEGF10 | ENST00000418761.6 | TSL:1 | c.1514G>A | p.Gly505Glu | missense | Exon 13 of 15 | ENSP00000416284.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000716 AC: 18AN: 251368 AF XY: 0.0000736 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461888Hom.: 0 Cov.: 30 AF XY: 0.0000220 AC XY: 16AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
MEGF10-related myopathy Uncertain:1
This sequence change replaces glycine with glutamic acid at codon 505 of the MEGF10 protein (p.Gly505Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant is present in population databases (rs199699950, ExAC 0.03%). This variant has not been reported in the literature in individuals with MEGF10-related conditions. ClinVar contains an entry for this variant (Variation ID: 582817). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at